VALN
Valneva SE
$5.36
+1.23%
$464.3M
No data for this timeframe.
Vol
Market Cap$464.3M
Cap SizeSmall Cap
Inst. Holders5 funds
Inst. Value$792.3K
Inst. Activity2 buys / 0 sells
Reddit Sentiment67° Warm
SEC Reports4
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. I0·CIK 0001836564·Prev Close $5.29
Recent Activity
Jun 5, 2026
SEC
Valneva filed a 6-K announcing the availability of documentation for its Annual General Meeting scheduled for June 25, 2
6-K — Impact 2/10
Jun 1, 2026
SEC
Valneva announced participation in investor conferences (Jefferies, Oddo BHF, BNP Paribas) and a travel medicine confere
6-K — Impact 2/10
May 5, 2026
SEC
Valneva announced it will report Q1 2026 financial results on May 13, 2026. The press release contains no financial data
6-K — Impact 2/10
Inst.
MORGAN STANLEY — ADD
42,981 shares ($379.1K)
Inst.
RHUMBLINE ADVISERS — DOUBLED
1,763 shares ($15.5K)
Price Targets
Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$12.20 (Sep 2025)
Current $5.36
Low $4.80
Median $13.00
High $18.00
4 analysts
$4.80
$18.00
Analyst Ratings
4Strong Buy
6Buy
1Hold
1Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 8, 2025 | Guggenheim | MAINTAIN | Buy → Buy |
| Aug 25, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 8, 2025 | Guggenheim | MAINTAIN | Buy → Buy |
| Apr 15, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Apr 9, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.08 ▲ +68.0% | $-0.08 — $-0.08 | 51% YoY | 1 |
| Next Q | $-0.13 ▲ +67.5% | $-0.13 — $-0.13 | 78% YoY | 1 |
| Current FY | $-1.23 ▲ +27.2% | $-1.23 — $-1.23 | 21% YoY | 1 |
| Next FY | $1.04 ▲ +28.4% | $1.04 — $1.04 | 185% YoY | 1 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| WELLS FARGO & COMPANY/MN | $487.7K | TRIM |
| MORGAN STANLEY | $293.3K | ADD |
| RHUMBLINE ADVISERS | $11.2K | DOUBLED |
| HRT FINANCIAL LP | $130.00 | — |
| Allworth Financial LP | $44.00 | — |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
5 institutional holders with $792.3K total value (147,601 shares) as of 2026-Q1. Top holders: WELLS, MORGAN, RHUMBLINE.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | WELLS FARGO & COMPANY/MN | 78,029 | $487.7K | 61.5% | TRIM -37.2% |
| 2 | MORGAN STANLEY | 46,925 | $293.3K | 37.0% | ADD +30.3% |
| 3 | RHUMBLINE ADVISERS | 1,793 | $11.2K | 1.4% | DOUBLED +708.7% |
| 4 | HRT FINANCIAL LP | 20,847 | $130.00 | 0.0% | — |
| 5 | Allworth Financial LP | 7 | $44.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 32,987 | 42,981 | +30.3% | $379.1K | 2025-Q4 |
| RHUMBLINE ADVISERS | DOUBLED | 218 | 1,763 | +708.7% | $15.5K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 245,177 | 153,990 | -37.2% | $1.9M | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 8,036 | 32,987 | +310.5% | $402.4K | 2025-Q3 |
| CITADEL ADVISORS LLC | TRIM | 35,738 | 16,410 | -54.1% | $200.2K | 2025-Q3 |
| UBS Group AG | DOUBLED | 1 | 472 | +47100.0% | $5.8K | 2025-Q3 |
| RHUMBLINE ADVISERS | DOUBLED | 51 | 218 | +327.5% | $2.7K | 2025-Q3 |
| RHUMBLINE ADVISERS | TRIM | 174 | 51 | -70.7% | $288.00 | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 37 | 1 | -97.3% | $6.00 | 2025-Q2 |
| MORGAN STANLEY | ADD | 2,725 | 5,204 | +91.0% | $34.9K | 2025-Q1 |
| MORGAN STANLEY | ADD | 1,979 | 3,556 | +79.7% | $21.5K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 2.3/10.
NEUTRAL
6-K
2/10
Valneva filed a 6-K announcing the availability of documentation for its Annual General Meeting sche
Jun 5, 2026
NEUTRAL
6-K
2/10
Valneva announced participation in investor conferences (Jefferies, Oddo BHF, BNP Paribas) and a tra
Jun 1, 2026
NEUTRAL
6-K
2/10
Valneva announced it will report Q1 2026 financial results on May 13, 2026. The press release contai
May 5, 2026
NEUTRAL
6-K
3/10
Valneva announced its participation in the 26th World Vaccine Congress in Washington, DC, where it w
Mar 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Sep 2025): 83% buy across 12 analysts — 4 strong buy, 6 buy, 1 hold, 1 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$12.20 mean target (Sep 2025)
$4.80 Low
$18.00 High
| Metric | Value |
|---|---|
| Current Price | $5.36 |
| Target Low | $4.80 |
| Target Mean | $12.20 |
| Target Median | $13.00 |
| Target High | $18.00 |
| # Analysts | 4 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.08 | $-0.08 | $-0.08 | 50.7% | +68.0% | 1↑ 0↓ | $0.0B | -22.0% | 1 |
| Next Q 2026-09-30 |
$-0.13 | $-0.13 | $-0.13 | 78.3% | +67.5% | 1↑ 0↓ | $0.0B | 19.1% | 1 |
| Current FY 2026-12-31 |
$-1.23 | $-1.23 | $-1.23 | 20.9% | +27.2% | 1↑ 0↓ | $0.2B | -13.1% | 1 |
| Next FY 2027-12-31 |
$1.04 | $1.04 | $1.04 | 184.5% | +28.4% | 1↑ 0↓ | $0.3B | 93.7% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.080 | |
| 7d ago | $-0.250 | +0.170 |
| 30d ago | $-0.250 | +0.170 |
| 60d ago | $0.000 | -0.080 |
| 90d ago | $0.000 | -0.080 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Sep 8, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Aug 25, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 8, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Apr 15, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 9, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 2, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 31, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 24, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 24, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Mar 21, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 28, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 19, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Feb 5, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 31, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 23, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Jan 22, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Oct 11, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Sep 25, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Sep 3, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 2, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jul 22, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 28, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 24, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 4, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 31, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 23, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 8, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 22, 2024 | Guggenheim | MAINTAIN | Buy | Buy |
| Mar 21, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 29, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Feb 15, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Dec 4, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Nov 10, 2023 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Sep 27, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Sep 7, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 29, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 28, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 30, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 5, 2023 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Feb 21, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| Feb 17, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| Feb 15, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| Aug 22, 2022 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Aug 3, 2022 | HC Wainwright & Co. | INITIATE | — | Buy |
| Jun 1, 2021 | Jefferies | INITIATE | — | Buy |
| Jun 1, 2021 | Goldman Sachs | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 6 | 1 | 1 | 0 | 83% | |
| May 1, 2026 | 4 | 6 | 1 | 1 | 0 | 83% | |
| Apr 1, 2026 | 3 | 7 | 2 | 0 | 0 | 83% | |
| Mar 1, 2026 | 3 | 6 | 2 | 0 | 0 | 82% | |
| Feb 1, 2026 | 3 | 6 | 2 | 0 | 0 | 82% | |
| Jan 1, 2026 | 3 | 6 | 2 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 12, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 12, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
VALN -Valneva Tick Ticker 💰🪲
▲ 1
💬 0
⚡ 0.5
Jun 4, 2026
Clinical Trial
A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents
Phase Phase 3 — COMPLETED